(Q29615330)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19528959

30 April 2017

1 reference

Clostridium difficile

0 references

1 reference

Rupnik M

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19528959

30 April 2017

Wilcox MH

series ordinal

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19528959

30 April 2017

Gerding DN

series ordinal

3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19528959

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19528959

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

July 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19528959

Nature Reviews Microbiology

30 April 2017

published in

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19528959

30 April 2017

volume

7

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19528959

30 April 2017

issue

7

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19528959

30 April 2017

page(s)

526-36

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19528959

Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications

30 April 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Toxin B is essential for virulence of Clostridium difficile

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Repression of Clostridium difficile toxin gene expression by CodY.

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Response to the article: McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic-associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006; 101:812-22

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism

1 May 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Clostridium difficile–associated diarrhea: an emerging threat to pregnant women

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRMICRO2164

31 March 2020

12 December 2020

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Emergence of Clostridium difficile-associated disease in North America and Europe.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Clostridium difficile surveillance trends, Saxony, Germany

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Rates of Clostridium difficile infection in patients discharged from Spanish hospitals, 1997-2005.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

An epidemic, toxin gene-variant strain of Clostridium difficile

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-rep

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Use of highly discriminatory fingerprinting to analyze clusters of Clostridium difficile infection cases due to epidemic ribotype 027 strains

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Clostridium difficile toxinotype V, ribotype 078, in animals and humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Epidemiology of community-acquired Clostridium difficile-associated diarrhea

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

A case-control study of community-associated Clostridium difficile infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

The distribution of Clostridium difficile in the environment of South Wales.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Clostridium difficile in retail ground meat, Canada

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Clostridium difficile in retail meat products, USA, 2007

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Toxinotype V Clostridium difficile in humans and food animals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Is Clostridium difficile-associated infection a potentially zoonotic and foodborne disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Clostridium difficile: an important pathogen of food animals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Clostridium difficile PCR ribotypes in calves, Canada

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

The comparative pathology of Clostridium difficile-associated disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves, and other species

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Prevention of fatal Clostridium difficile-associated disease during continuous administration of clindamycin in hamsters

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Susceptibility of hamsters to human pathogenic Clostridium difficile strain B1 following clindamycin, ampicillin or ceftriaxone administration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Emergence of reduced susceptibility to metronidazole in Clostridium difficile

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Metronidazole resistance in Clostridium difficile is heterogeneous

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Clinical recognition and diagnosis of Clostridium difficile infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Clostridium difficile associated diarrhoea: how good are nurses at identifying the disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Does the nose know? The odiferous diagnosis of Clostridium difficile-associated diarrhea

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Diagnosis of Clostridium difficile-associated diarrhea and odor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Treatment of Clostridium difficile colitis and diarrhea with vancomycin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Relapse versus reinfection withClostridium difficile

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Effects of Clostridium difficile toxins on epithelial cell barrier.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Identification of Clostridium difficile toxin B cardiotoxicity using a zebrafish embryo model of intoxication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

The ClosTron: a universal gene knock-out system for the genus Clostridium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Large clostridial cytotoxins--a family of glycosyltransferases modifying small GTP-binding proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

A novel toxin homologous to large clostridial cytotoxins found in culture supernatant of Clostridium perfringens type C.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Glucosylation of Rho proteins by Clostridium difficile toxin B.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

gp96 is a human colonocyte plasma membrane binding protein for Clostridium difficile toxin A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Autocatalytic cleavage of Clostridium difficile toxin B.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on cysteine protease activity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Clostridium difficile toxin expression is inhibited by the novel regulator TcdC

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Evidence for holin function of tcdE gene in the pathogenicity of Clostridium difficile

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Definition of the single integration site of the pathogenicity locus in Clostridium difficile.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Revised nomenclature of Clostridium difficile toxins and associated genes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Heterogeneity of large clostridial toxins: importance of Clostridium difficile toxinotypes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Clostridium difficile toxin synthesis is negatively regulated by TcdC.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Effects of exposure of Clostridium difficile PCR ribotypes 027 and 001 to fluoroquinolones in a human gut model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Binary toxin production in Clostridium difficile is regulated by CdtR, a LytTR family response regulator

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Patterns of sequence conservation in the S-Layer proteins and related sequences in Clostridium difficile

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Human antibody response to surface layer proteins in Clostridium difficile infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Proteomic analysis of cell surface proteins from Clostridium difficile

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Variability of Clostridium difficile surface proteins and specific serum antibody response in patients with Clostridium difficile-associated disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Surface layer proteins from Clostridium difficile induce inflammatory and regulatory cytokines in human monocytes and dendritic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Hospital disinfectants and spore formation by Clostridium difficile

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Nosocomial acquisition of Clostridium difficile infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Environmental control to reduce transmission of Clostridium difficile

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Systematic review of antimicrobial drug prescribing in hospitals.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2164

A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates.

31 March 2020

1 reference

12 December 2020

Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008.

1 reference

12 December 2020

Reduction in vancomycin-resistant Enterococcus and Clostridium difficile infections following change to tympanic thermometers

1 reference

12 December 2020

Surveillance for community-associated Clostridium difficile--Connecticut, 2006.

1 reference

12 December 2020

Interventions to improve antibiotic prescribing practices for hospital inpatients

1 reference

12 December 2020

Effects of Clostridium difficile toxins given intragastrically to animals

1 reference

12 December 2020

Increased number of Clostridium difficile infections and prevalence of Clostridium difficile PCR ribotype 001 in southern Germany

1 reference

12 December 2020

Severe Clostridium difficile-associated disease in populations previously at low risk--four states, 2005.

1 reference

12 December 2020

Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196.

1 reference

12 December 2020

A randomized crossover study of disposable thermometers for prevention of Clostridium difficile and other nosocomial infections

1 reference

12 December 2020

Cytotoxic effects of the Clostridium difficile toxins

1 reference

12 December 2020

Inappropriate use of meta-analysis to estimate efficacy of probiotics

1 reference

12 December 2020

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19528959

Identifiers

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1026512210

0 references

1 reference

Consolidated OpenCitations Corpus – April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19528959

PubMed publication ID

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017